The trademark application IZBO was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on March 6, 2023, and it was registered by office on June 13, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).